HOME
Professional publications

Per visualizzare correttamente i documenti in pdf è necessaria la versione 6.0 di Acrobat Reader. Clicca qui per scaricarla

2006
 
Predictors of liver fibrosis in HIV-infected patients with chroninc hepatitis C virus (HCV) infection: assessment using transient elastometry and the rote of HCV genotype 3.; Clinical Infectious Deseases, 2006; 42(7): 1032-9
P. Barreiro, L. Martin-Carbonero, M. Nunez, P. Rivas, A. Morente, N. Simarro, P. Labarga, J. Gonzales- Lahoz, V. Soriano
 
 
 
2005
 
Assessment of biliary fibrosis by transient elastography in PBC and PSC patients; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
C. Corpechot, A. El Naggar, A. Poujol-Robert, M. Ziol, D. Wendum, O. Chazouillères, V. de Lédinghen, D. Dhumeaux, P. Marcellin, M. Beaugrand, R. Poupon
 
 
Non-invasive assessment of liver fibrosis in chronic hepatitis B using Fibroscan™; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
P. Marcellin, V. de Ledinghen, D. Dhumeaux, R. Poupon, M. Ziol, P. Bedossa, M. Beaugrand;
 
 
Accuracy of liver stiffness measurement (LSM) for the diagnosis of cirrhosis in patients with chronic liver diseases (CLD); a study in 1345 patients; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
N. Ganne-Carrie, V. de Ledinghen, C. Douvin, P. Marcellin, L. Castéra, M. Ziol, M. Beaugrand
 
 
Fibroscan™ is a new non-invasive method for the diagnosis of liver fibrosis in children: a prospective comparison with Fibrotest, and liver biopsy; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
V. de Lédinghen, B. Le Bail, L. Rebouissoux, J. Foucher, L. Castéra, M. Darriet, T. Lamireau
 
 
Diagnosis of hepatic fibrosis and cirrhosis by liver stiffness measurement in HIV-HCV co-infected patients: a prospective study; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
V. de Lédinghen, C. Douvin, A. Kettaneh, M. Ziol, D. Riol, M. Ziol, D. Dhumeaux, M. Beaugrand  
 
 
Prevalence and factors associated with failure of liver stiffness measurement using Fibroscan™ in a prospective study of 2114 examinations; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
J. Foucher, L. Castéra, P-H Bernard, X. Adhoute, D. Laharie, J. Bertet, P. Couzigou, V. de Lédinghen
 
 
Repeated liver stiffness measurement using Fibroscan™ for the follow-up of untreated HCV patients and for the evaluation and monitoring of histological response in HCV responders: a prospective longitudinal study; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
V. de Lédinghen, L. Castéra, J. Foucher, P-H Bernard, R. Tounan, N. Le Provost, P. Couzigou
 
 
Interest of the Fibroscan™ in the screening of cirrhosis in patients attending alcoholism consultation; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
P. Mellin, A. Dacon, A. Gauchet, M. Schoeny, C. Fournier, L. Sandrin, M-D Diebold
 
 
Amount and type of liver fibrosis detected by stiffness measurement; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
M. Ziol, N. Berget, A. Kettaneh, N. Ganne-Carrie, M. Beaugrand
 
 
Liver stiffness and biomarkers: correlation with extent of fibrosis, portal hypertension and hepatic synthetic function; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
A. Khokhar, R. Farnan, C. Macfarlane, B. Bacon, J. McHutchinson, N. Afdhal
 
 
Prospective analysis of discordance between Fibroscan™ and FibroTest when used in combination as first-line assessment of liver fibrosis in chronic hepatitis C; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
L. Castéra, B. Le Bail, J. Foucher, M. Darriet, P. Couzigou, V. de Lédinghen
 
 
Clinical glycomics for non-invasive assessment of liver fibrosis in chronic hepatitis C: independent validation and comparison with Fibroscan™, FibroTest and liver biopsy; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
L. Castéra, A. Van Hecke, P. Trimoulet, N. Callewaert, P. Couzigou, , V. de Lédinghen, R. Contreras, W. Laroy
 
 
Transient elastography: A new and useful non-invasive method for assessing liver damage progression in primary 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
A. Parés, L. Caballeria, E. Lázaro, A. Garcia-Criado, M. Navata, R. Gilabert
 
 
Non invasive assessment for liver graft fibrosis by transient elastography after liver transplantation; 56th Annual Meeting of the American Association for the Study of Liver Disease, November 11-15, 2005, San Francisco, United States
C. Barrault, F. Medkauer, C. Atanasiu, C. Douvin, F. Roudot-Thoraval, A. Mallat, E-S Zafrani, C. Dovoux, J. Tran Van Nhieu
 
 
Interest of the Fibroscan™ for the screening of cirrhosis in alcoholism consultation; 67th Annual Scientific Meeting of the College on Problems of Drug Dependence, June 18-23 , 2005, Orlando, United States
P. Melin, L. Gourarier, A. Dacon, A. Gauchet, M. Schoeny, M-D Diebold
 
 
Interest of the Fibroscan™ in a toxicology consultation: Preliminary results; 67th Annual Scientific Meeting of the College on Problems of Drug Dependence, June 18-23 , 2005, Orlando, United States
L. Gourarier, P. Melin, J-P Lang
 
 
Fibroscan™ is a new non-invasive method for the diagnosis of liver fibrosis in children: A prospective comparison with FibroTest® and liver biopsy; 38th Annual Meeting of the European Society of Pardiatric Gastroenterology Hepatology and Nutrition, June 1-4, 2005, Porto, Portugal
T. Lamireau, B. Le Bail, L. Rebouissoux, L. Castéra, J. Foucher, M. Darriet, V. de Lédinghen
 
 
In patients with cirrhosis, liver stiffness measurement (LSM) predicts the presence and size of oesophageal varices (OV) more accurately than portal gradient (PG); 40th Annual Meeting of the European Association for the Study of Liver, April 13-17, 2005, Paris, France
F. Kazemi, E. Pinto, G. Nkontchou, N. Ganne, J-C Trinchet, M. Beaugrand
 
 
Fibrosis evaluation in chronic liver diseases: Comparison of Fibroscan™ with liver biopsy, FibroTest®, Forns score, APRI, Hyaluronan, Prothrombin time, and AST/ALT ratio; 40th Annual Meeting of the European Association for the Study of Liver, April 13-17, 2005, Paris, France
J. Foucher, J. Vergignol, L. Castéra, B. Le Bail, E. Chanteloup, M. Darriet, J. Bertet, P. Couzigou, V. de Lédinghen
 
 
Interest of the Fibroscan™ in the screening of cirrhosis in patient attending alcoholism consultation; 40th Annual Meeting of the European Association for the Study of Liver, April 13-17, 2005, Paris, France
P. Melin, A. Dacon, A. Gaughet, M. Schoeny, M-D Diebold  
 
 
Monitoring liver elasticity a new tool to measure liver fibrosis during therapy; 40th Annual Meeting of the European Association for the Study of Liver, April 13-17, 2005, Paris, France
B. Coco, F. Oliveri, P. Colombatto, P. Ciccorossi, R. Sacco, F. Bonino, M. R. Brunetto
 
 
La mesure de l'elasticite du foie permet de prevoir la presence de varices oesophagiennes chez les malades attent de cirrhose; 29eme Les Journees Francophones de Pathologie Digestive, Avril 2-6, 2005, Paris, France
F. Kazemi, E. Pinto, G. Nkontchou, N. Ganne, J-C Trinchet, M. Beaugrand
 
 
Interet du Fibroscan™ dans le depistage de la cirrhose chez les patients de consultation d'alcoologie; 29eme Les Journees Francophones de Pathologie Digestive, Avril 2-6, 2005, Paris, France
P. Melin, A. Dacon, A. Gaughet, M. Schoeny, M-D Diebold
 
 
Le Fibroscan™, une nouvelle methode non-invasive pour l'evaluation de la fibrose hepatique: resultats d'une etude prospective comparative avec la biopsie hepatique, le FibroTest®, l'acide hyaluronique, le taux de prothrombine, le score APRI, le ratio ASAT/ALAT, et le score de Forns; 29eme Les Journees Francophones de Pathologie Digestive, Avril 2-6, 2005, Paris, France
J. Foucher, J. Vergignol, L. Castéra, B. Le Bail, E. Chanteloup, M. Darriet, N. Le Provost, P. Couzigou, V. de Lédinghen
 
 
Quelle est le signification clinique du Fibroscan™ au cours de la cirrhose? Resultats d'une etude prospective; 29eme Les Journees Francophones de Pathologie Digestive, Avril 2-6, 2005, Paris, France
E. Chanteloup, J. Vergignol, L. Castéra, J. Foucher, J. Bertet, N. Darrieutort, P. Couzigou, V. de Lédinghen
 
 
Le Fibroscan™, une nouvelle methode non-invasive pour l'evaluation de le fibrose hepatique chez l'enfant: : resultats d'une etude prospective comparative avec le FibroTest® et la biopsie hepatique; 29eme Les Journees Francophones de Pathologie Digestive, Avril 2-6, 2005, Paris, France
T. Lamireau, B. Le Bail, L. Rebouissoux, J. Foucher, L. Castéra, M. Darriet, V. de Lédinghen
 
 
 
2004
 
Non invasive assessment of liver fibrosis by liver stiffness measurements (LSM) in patients with chronic hepatitis C (CHC): the importance of sampling; 55th Annual Meeting of the American Association for the Study of Liver Diseases; October 29 – November 2nd, 2004, Boston, United-States
M. Ziol, A.Handra-Luca, A. Kettaneh, C. Christidis, F. Mal, F. Kazemi, V. de Lédinghen, P. Marcelin, D. Dhumeaux, J-C. Trinchet, M. Beaugrand
 
 
Liver stiffness measurement is highly predictive of the presence of oesophageal varices grade II-III in patients with cirrhosis; 55th Annual Meeting of the American Association for the Study of Liver Diseases; October 29 – November 2nd, 2004, Boston, United-States
F. Kazemi, E. Pinto, G. Ntontchou, N, Ganne Carrie, J-C. Trinchet, M. Beaugrand
 
 
Liver stiffness measurement (LSM) improves prediction of fibrosis stage by experienced physicians in patients with HCV chronic hepatitis; 55th Annual Meeting of the American Association for the Study of Liver Diseases; October 29 – November 2nd, 2004, Boston, United-States
P. Nahon, M. Ziol, A.Handra-Luca, J-C. Trinchet, M. Beaugrand
 
 
Transient elastography (Fibroscan™) a novel, non-invasive sensitive method for the assessment of liver fibrosis in chronic hepatitisC. A prospective evaluation in comparison with liver biopsy, Fibrotest and APR; 55th Annual Meeting of the American Association for the Study of Liver Diseases; October 29 – November 2nd, 2004, Boston, United-States
L. Castéra, J, Vergniol, J. Foucher, B. Le Bail, E. Chanteloup, M. Haaser, N. Le Provost, P. Couzigou, V. de Lédinghen  
 
 
Fibroscan™ is a new non invasive method for the detection of cirrhosis and its complications in patients with chronic liver diseases. Results of a prospective study in 456 patients; 55th Annual Meeting of the American Association for the Study of Liver Diseases; October 29 – November 2nd, 2004, Boston, United-States
E. Chanteloup, J. Foucher, L. Castéra, J. Vergignol, M. Haaser, J. Bertet, P. Couzigou, V. de Lédinghen  
 
 
Independent prospepctive validation of the use of liver stiffness measurement to assess liver fibrosis in patients with chronic viral hepatitis; 55th Annual Meeting of the American Association for the Study of Liver Diseases; October 29 – November 2, 2004, Boston, United-States
C. Douvin, F. Roudot-Thoraval, J. Tran Van Nhieu, E.S. Zafrani, D. Dhumeaux
 
 
La mesure de l’elasticité du foie (MEF) améliore la prédiction du score de fibrose par le clincien expérimenté chez les malades ayant une hépatite chronique C; 55èmes Journêes de l’Association Française pour l’Etude du Foie, September 29 – October 2, 2004, Paris, France.
P. Nahon, M. Ziol, A.Handra-Luca, J-C. Trinchet, M. Beaugrand
 
 
Le Fibroscan™: une nouvelle méthode non invasive de diagnostic de la cirrhose et de ses complications au cours des maladies chroniques du foie: Résultats d’une etude prospective chez 456 malades; 55èmes Journêes de l’Association Française pour l’Etude du Foie, September 29 – October 2, 2004, Paris, France
J. Vergignol, E. Chanteloup, J. Foucher, L. Castéra, M. Haaser, J. Bertet, P. Couzigou, V. de Lédinghen  
 
 
Le Fibroscan™: une nouvelle méthode non invasive pour l’évaluation de la fibrose hépatique dans l’hepatite chronique C: resultats d’une etude prospective comparative avec la biopsie hepatique, le FibroTest® et le score APRI; 55èmes Journêes de l’Association Française pour l’Etude du Foie, September 29 – October 2, 2004, Paris, France
L. Castéra, J, Vergniol, J. Foucher, B. Le Bail, E. Chanteloup, M. Haaser, N. Le Provost, P. Couzigou, V. de Lédinghen
 
 
Performances de la mesure de l’élasticité hépatique (MEH) pour le diagnostic de cirrhose au corse des maladieschrniques du foie (MCF): etude multicentrique chez 1345 maladies; 57émes Journêes de l’Association Française pour l’Etude du Foie, September 29 – October 2, 2004, Bordeaux, France
N. Ganne-Carrie, V. de Lédinghen, C. Douvin, P. Marcellin, L. Castéra, M. Ziol, M. Beaugrand
 
 
Intérèt de l’élastographie impulsionelle pour l’evaluation de la fibrose hépatique au cours des maladies cholestatiques chronique; 57émes Journêes de l’Association Française pour l’Etude du Foie, September 29 – October 2, 2004, Bordeaux, France
C. Corperchot, A. Ei Naggar, A. Poujol-Robert, M. Ziol, D. Wendum, O. Chazouilieres, V. de Lédinghen, D. Dhumeaux, P. Marcellin, M. Beaugrand, R.Poupon
 
 
Evaluation non invasive de la fibrose chez les patients atteinta d’hépatite B chronique avec le Fibroscan™; 57émes Journêes de l’Association Française pour l’Etude du Foie, September 29 – October 2, 2004, Paris, France
P. Marcellin, V. de Lédinghen, D. Dhumeaux, R.Poupon, M. Ziol, P. Bedossa, M. Beaugrand
 
 
Analyse prospective de la prevalence et des causes de discordances entre Fibroscan™ et Fibrotestlors de leur utilisation combine en première intention pour l’évaluation non invasive de la fibrose chez les malades atteints d’hépatite chroniqueC (HCC); 57émes Journêes de l’Association Française pour l’Etude du Foie, September 29 – October 2, 2004, Bordeaux, France
L. Castéra, B. Le Bail, J. Fouchet, P.H. Bernard, J. Bertet, M. Darriet, P. Cozigou, V. de Lédinghen
 
 
“Glycomique clinique”: validation indépendante et comparaison avec le Fibroscan™ et le Fibrotestpour l’évaluation non invasive de la fibrose au cours de l’hépatite chronique C; 57émes Journêes de l’Association Française pour l’Etude du Foie, September 29 – October 2, 2004, Bordeaux, France
L. Castéra, A. Van Hecke, P. Trimoulet, N. Callewaert, L. Castéra, P. Cozigou, V. de Lédinghen, R. Contreras, W. Laroy
 
 
Diagnostic del afibrose hépatique et de la cirrhose par mesure de l’élasticité hépatique xhez les malades co-infectés VIH-VHC. Etude prospective multicentrique; 57émes Journêes de l’Association Française pour l’Etude du Foie, September 29 – October 2, 2004, Bordeaux, France
V. de Lédinghen, C. Douvin, A. Kettaneh,M. Ziol, D. Roulot, P. Marcellin, D. Dhumeaux, M. Beaugrand
 
 
Le Fibroscan™ permet le diagnostic non-invasif de la fibrose hépatique chex l’enfant: comparison prospective avec le Fibrotest et la ponction biopsie hépatique; 57émes Journêes de l’Association Française pour l’Etude du Foie, September 29 – October 2, 2004, Bordeaux, France
T. Lamireau, B. Le Bail, L. Rebouissoux, J. Foucher, L. Castéra, M. Darriet, V. de Lédinghen
 
 
Correlation between liver elasticity measured by transient elastography and liver fibrosis assessed by morphometry in patients with HCV chronin hepatitis; 39th Annual Meeting of the European Association for the Study for the Liver, April 14-18, 2004, Berlin, Germany
M. Ziol, N. Barget, L. Sandrin, C. Fourneir, A. Kettaneh, F. Mal, F. Kazemi, M. Beaugrand  
 
 
Efficacy of non invasive elastometry on staging of hepatic fibrosis; Keio University & Society of Highly Advanced Medical Technology, 2004, Tokyo, Japan
H. Saito, S. Tada, N. Nakamoto, K. Kitamura, H. Horikawa, S. Kurita, Y. Saito, H. Iwai, H. Ishii
 
 
Une nouvelle methode non invasive de quantification de la fibrose hepatique: l'elastographie impulsionnelle - Resultats chez 220 malades atteints d'hepatite chronique virale.
M. Beaugrand, M. Ziol, L. Sandrin, C. Fournier, A. Biaggi-Frassati, B. Poulet, J.C. Trinchet, F. Mal, C. Christidis, F. Kazemi, N. Ganne and R. Palau
 
 
 
2003
 
Transient elastography A new non invasive method for assessment of liver fibrosis: results in patients with HCV chronic hepatitis. 38th Meeting of the Europaean Association for the Study of the Liver, July 3-6, 2003, Palexpo, Geneva, Switzerland
R. Palau, F. Mal, C. Christidis, M. Ziol, L. Sandrin, C. Fournier, B. Fourquet, M. Beaugrand
 
 
Liver elasticità by ultrasonic transient elastography: a new non-invasive method for assessment of liver fibrosis in chronic viral hepatitis; 54th Annual Meeting for the American Association for the Study of Liver Diseases, October 24-28, 2003, Boston, United States
Beaugrand, M. Ziol, L. Sandrin, C. Fournier,A. Biaggi-Frassati, B. Poulet, J-C. Trinchet, F. Mal, C. Christidis, F. Kazemi, V. Grando, N. Ganne, R. Palau
 
 
L'elasticite du foie est-elle un reflet de la fibrose hepatique ou peut-on evaluer la fibrose par une methode non invasive? Resultats de l'etude pilote par elastographie.
C. Christidis, L. Sandrin, R. Palau, M. Ziol, B. Fourquest, F. Mal, P. Callard, M. Beaugrand, C. Fournier, B. Gayet
 
 
 
2002
 
Noninvasive tissue elasticity probe, 88th Scientific Assembly and Annual Meeting of Radiological Society of North America, December 1-6, 2002, McCormick Place, Chicago, USA
R. Palau, L. Sandrin, J-M. Hasquenoth, S. Yon, C. Fourneir, B. Fourquet
 
 
Noninvasive evaluation of the hepatic fibrosis using transient elastography, 88th Scientific Assembly and Annual Meeting of Radiological Society of North America, December 1-6, 2002, McCormick Place, Chicago, USA
C. Christidis, F. Mal, M. Beaugrand, N. Bouzar, C. Strauss, G. Seguin, S. Lenoir, L. Fontanelle, M. Zins, R. Palau, L. Sandrin, C. Fourneir, B. Fourquet
 
 
Identification of Chronic Hepatitis C Patients Without Hepatic Fibrosis by a Simple Predictive Model
Xavier Forns, Sergi Ampurdanès, Josep M. Llovet, John Aponte, Llorenc¸ Quintò, Eva Martìnez-Bauer, Miquel Bruguera, Jose Maria Sànchez-Tapias, and Juan Rodès
 

 

Sede legale: AXSAN s.r.l. Via Leone XIII, 14 - 20145 Milano - C.F. e P. IVA 05422360965
Registro dei Produttori AEE: IT08020000001087 del 15/2/08
© 2012 - webmaster: Graphia Studio, Pavia - © Axsan srl 2008